TY - JOUR
T1 - Salmon calcitonin in the treatment of postmenopausal osteoporosis
AU - Fatourechi, V.
AU - Heath, H.
PY - 1987/1/1
Y1 - 1987/1/1
N2 - In conclusion, there are few rigorous and no definitive studies about the effect of salmon calcitonin on post-menopausal osteoporosis, and none exceed about 2 years of follow-up. The evidence so far indicates that daily or alternative day injections of salmon calcitonin in combination with oral calcium may reduce bone resorption and increase bone density in some women with postmenopausal osteoporosis. However, the bone gain is small and may start to reverse within 12 to 20 months, despite continued therapy.
AB - In conclusion, there are few rigorous and no definitive studies about the effect of salmon calcitonin on post-menopausal osteoporosis, and none exceed about 2 years of follow-up. The evidence so far indicates that daily or alternative day injections of salmon calcitonin in combination with oral calcium may reduce bone resorption and increase bone density in some women with postmenopausal osteoporosis. However, the bone gain is small and may start to reverse within 12 to 20 months, despite continued therapy.
UR - http://www.scopus.com/inward/record.url?scp=0023555301&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023555301&partnerID=8YFLogxK
U2 - 10.7326/0003-4819-107-6-923
DO - 10.7326/0003-4819-107-6-923
M3 - Review article
C2 - 3318613
AN - SCOPUS:0023555301
SN - 0003-4819
VL - 107
SP - 923
EP - 925
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
IS - 6
ER -